Skip to content

Clinical trials

Phase 2 Waldenstrom Macroglobulinemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Country / region: Italy Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20111
20142
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
Acerta Pharma BV1
BeOne Medicines1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Italiana Linfomi - ETS1
Gilead Sciences1
Kite, A Gilead Company1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia11
Lymphoma, Non-Hodgkin7
Leukemia, Lymphocytic, Chronic, B-Cell6
Burkitt Lymphoma5
Hodgkin Disease5
Leukemia, Hairy Cell5
Leukemia, Myeloid, Acute5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Follicular5
Multiple Myeloma5

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.